3 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
Follow AZD0466: new trials by email Literature Review of AZD0466 trials Research Report on AZD0466
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma AZD0466 - Non-Hodgkin Lymphoma | Phase 1 | Terminated | AstraZeneca | 7 | 2022-07-05 | 2025-01-07 |
| Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies AZD0466, Voriconazole - Haematological Malignancies | Phase 1 | Terminated | AstraZeneca | 46 | 2021-06-11 | 2025-06-15 |
| A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors AZD0466 - Advanced Solid Tumors, Lymphoma | Phase 1 | Terminated | AstraZeneca | 9 | 2019-12-16 | 2023-08-02 |
Hematologic Neoplasms (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Recurrence (1) · Tumor Lysis Syndrome (1)
AstraZeneca (3)
United States (3) · Australia (2) · France (2) · Italy (2) · South Korea (2) · Germany (1) · Portugal (1) · Spain (1)